Exelixis (EXEL) Net Cash Flow (2010 - 2026)

Exelixis' (EXEL) quarterly Net Cash Flow came in at -$256.3 million in Q2 2026, down 662.41% year-on-year from $45.6 million in Q2 2025, and down 341.4% quarter-over-quarter from $106.2 million in Q1 2026.

Exelixis (EXEL) Net Cash Flow (2010 - 2026) Analysis & Trends

Exelixis' Net Cash Flow history runs 17 years deep, the most recent figure standing at -$256.3 million for Q2 2026.

  • On a quarterly basis, Net Cash Flow fell 662.41% year-over-year to -$256.3 million in Q2 2026; TTM through Apr 2026 was $42.4 million, a 155.93% increase from a year earlier, with the FY2026 full-year figure at $265.1 million, up 681.14% from the prior year.
  • Net Cash Flow eased to -$256.3 million in Q2 2026 per EXEL's latest filing, from $106.2 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $211.9 million in Q4 2025 and bottomed at -$256.3 million in Q2 2026.
  • The 5-year median for Net Cash Flow is -$33.6 million (2025), against an average of -$25.7 million.
  • Across the five-year window, Net Cash Flow sank 879.38% in 2025 and soared 359.17% in 2026, its largest moves.
  • Year by year, Net Cash Flow stood at -$174.1 million in 2022, then increased by 23.11% to -$133.9 million in 2023, then surged by 144.74% to $59.9 million in 2024, then jumped by 253.78% to $211.9 million in 2025, then tumbled by 220.99% to -$256.3 million in 2026.
  • Per Business Quant, the three latest EXEL Net Cash Flow figures stand at -$256.3 million (Q2 2026), $106.2 million (Q1 2026), and $211.9 million (Q4 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 10.56 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 224.46 Mn
4 NuCana 279.75 Bn 279.75 Bn - -1.34 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 457.40 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -152.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 57.19 Mn
10 Exelixis 14.38 Bn 13.60 Bn 590.86 Mn -256.34 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 -256.34 Mn
Apr 3, 2026 -256.34 Mn
Jan 2, 2026 106.19 Mn
Jan 2, 2026 106.19 Mn
Oct 3, 2025 211.87 Mn
Oct 3, 2025 211.87 Mn
Jul 4, 2025 -19.32 Mn
Jul 4, 2025 -19.32 Mn
Apr 4, 2025 -33.62 Mn
Apr 4, 2025 -33.62 Mn
Jan 3, 2025 -40.97 Mn
Jan 3, 2025 -40.97 Mn
Sep 27, 2024 59.89 Mn
Sep 27, 2024 59.89 Mn
Jun 28, 2024 -61.10 Mn
Jun 28, 2024 -61.10 Mn
Mar 29, 2024 -3.43 Mn
Mar 29, 2024 -3.43 Mn
Dec 29, 2023 -133.87 Mn
Dec 29, 2023 -133.87 Mn